Y-mAbs Therapeutics (YMAB) Director Ashu Tyagi Acquires 430,174 Shares
Y-mAbs Therapeutics (NASDAQ:YMAB) Director Ashu Tyagi acquired 430,174 shares of Y-mAbs Therapeutics stock in a transaction dated Tuesday, September 25th. The shares were purchased at an average price of $16.00 per share, with a total value of $6,882,784.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of NASDAQ:YMAB traded down $0.28 during trading on Thursday, reaching $24.44. 30,300 shares of the stock were exchanged, compared to its average volume of 927,926. Y-mAbs Therapeutics has a 12 month low of $22.50 and a 12 month high of $28.03.
Y-mAbs Therapeutics Company Profile
Further Reading: Do You Need a Fiduciary?
Receive News & Ratings for Y-mAbs Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Y-mAbs Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.